Xinhuosu (nesiritide)
/ China Medical System
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 31, 2025
A single-center, prospective controlled study on the efficacy of loose volume combined with recombinant human brain natriuretic peptide (Xinhuosu) in patients with acute exacerbation of chronic heart failure.
(ChiCTR)
- P=N/A | N=104 | Not yet recruiting | Sponsor: Ordos Central Hospital; Ordos Central Hospital
New trial • Cardiovascular • Congestive Heart Failure • Heart Failure
1 to 1
Of
1
Go to page
1